PROCTER & GAMBLE HEALTH | STRIDES PHARMA SCIENCE | PROCTER & GAMBLE HEALTH/ STRIDES PHARMA SCIENCE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.4 | -1,432.1 | - | View Chart |
P/BV | x | 10.5 | 3.2 | 325.3% | View Chart |
Dividend Yield | % | 2.0 | 0.2 | 1,037.7% |
PROCTER & GAMBLE HEALTH STRIDES PHARMA SCIENCE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
STRIDES PHARMA SCIENCE Mar-23 |
PROCTER & GAMBLE HEALTH/ STRIDES PHARMA SCIENCE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 392 | 1,368.1% | |
Low | Rs | 3,883 | 263 | 1,473.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 408.5 | 181.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | -25.6 | -540.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 1.4 | 11,342.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.50 | 6,333.3% | |
Avg Dividend yield | % | 2.1 | 0.5 | 449.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 242.8 | 184.3% | |
Shares outstanding (eoy) | m | 16.60 | 90.30 | 18.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.8 | 777.8% | |
Avg P/E ratio | x | 33.5 | -12.8 | -260.9% | |
P/CF ratio (eoy) | x | 29.8 | 239.6 | 12.4% | |
Price / Book Value ratio | x | 10.3 | 1.4 | 765.2% | |
Dividend payout | % | 68.7 | -5.9 | -1,171.4% | |
Avg Mkt Cap | Rs m | 76,761 | 29,603 | 259.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 7,320 | 28.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 36,884 | 33.3% | |
Other income | Rs m | 184 | 1,352 | 13.6% | |
Total revenues | Rs m | 12,480 | 38,236 | 32.6% | |
Gross profit | Rs m | 3,247 | 830 | 391.3% | |
Depreciation | Rs m | 281 | 2,433 | 11.6% | |
Interest | Rs m | 8 | 2,611 | 0.3% | |
Profit before tax | Rs m | 3,142 | -2,862 | -109.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -553 | -153.2% | |
Profit after tax | Rs m | 2,295 | -2,309 | -99.4% | |
Gross profit margin | % | 26.4 | 2.2 | 1,173.7% | |
Effective tax rate | % | 27.0 | 19.3 | 139.6% | |
Net profit margin | % | 18.7 | -6.3 | -298.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 31,353 | 37.4% | |
Current liabilities | Rs m | 6,791 | 29,902 | 22.7% | |
Net working cap to sales | % | 40.0 | 3.9 | 1,017.9% | |
Current ratio | x | 1.7 | 1.0 | 164.5% | |
Inventory Days | Days | 263 | 71 | 369.4% | |
Debtors Days | Days | 343 | 129 | 267.1% | |
Net fixed assets | Rs m | 10,617 | 31,300 | 33.9% | |
Share capital | Rs m | 166 | 903 | 18.4% | |
"Free" reserves | Rs m | 7,265 | 21,025 | 34.6% | |
Net worth | Rs m | 7,431 | 21,928 | 33.9% | |
Long term debt | Rs m | 0 | 11,398 | 0.0% | |
Total assets | Rs m | 22,330 | 63,734 | 35.0% | |
Interest coverage | x | 409.1 | -0.1 | -426,293.6% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 95.2% | |
Return on assets | % | 10.3 | 0.5 | 2,172.9% | |
Return on equity | % | 30.9 | -10.5 | -293.3% | |
Return on capital | % | 42.4 | -0.8 | -5,637.6% | |
Exports to sales | % | 0 | 46.7 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 17,213 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 18,113 | 8.1% | |
Fx outflow | Rs m | 1,605 | 672 | 239.1% | |
Net fx | Rs m | -140 | 17,442 | -0.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 444 | 531.4% | |
From Investments | Rs m | -215 | 3,025 | -7.1% | |
From Financial Activity | Rs m | -985 | -2,139 | 46.0% | |
Net Cashflow | Rs m | 1,160 | 1,328 | 87.4% |
Indian Promoters | % | 0.0 | 27.4 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.3 | 38.9 | 52.1% | |
FIIs | % | 7.6 | 19.5 | 39.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 72.6 | 66.4% | |
Shareholders | 56,730 | 91,182 | 62.2% | ||
Pledged promoter(s) holding | % | 0.0 | 69.2 | - |
Compare PROCTER & GAMBLE HEALTH With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | STRIDES PHARMA SCIENCE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.69% | -0.45% | 1.18% |
1-Month | -7.59% | -1.26% | -0.75% |
1-Year | -3.15% | 172.46% | 61.82% |
3-Year CAGR | -9.16% | -3.87% | 18.16% |
5-Year CAGR | 5.72% | 10.62% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the STRIDES PHARMA SCIENCE share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of STRIDES PHARMA SCIENCE.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of STRIDES PHARMA SCIENCE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.